tiprankstipranks
Editas Medicine Inc (EDIT)
NASDAQ:EDIT
US Market

Editas Medicine (EDIT) Income Statement

Compare
3,430 Followers

Editas Medicine Income Statement

Last quarter (Q4 2024), Editas Medicine's total revenue was $30.60M, a decrease of -49.03% from the same quarter last year. In Q4, Editas Medicine's net income was $-45.40M. See Editas Medicine’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 32.31M$ 78.12M$ 19.71M$ 25.54M$ 90.73M
Gross Profit
$ 32.31M$ -99.53M$ 13.38M$ 20.49M$ -67.26M
Operating Expenses
$ 283.47M$ 247.30M$ 245.66M$ 218.69M$ 225.57M
Depreciation and Amortization
$ 5.81M$ 6.06M$ 6.34M$ 5.05M$ 3.96M
EBITDA
$ -233.11M$ -163.12M$ -219.61M$ -188.09M$ -130.88M
Operating Income
$ -251.15M$ -169.18M$ -225.95M$ -193.15M$ -134.84M
Other Income/Expenses
$ 14.06M$ 15.96M$ 5.52M$ 644.00K$ 18.86M
Pretax Income
$ -237.09M$ -153.22M$ -220.43M$ -192.50M$ -115.98M
Net Income
$ -237.09M$ -153.22M$ -204.35M$ -185.11M$ -109.41M
Per Share Metrics
Basic EPS
$ -2.88$ -2.02$ -2.98$ -2.74$ -1.87
Diluted EPS
$ -2.88$ -2.02$ -2.98$ -2.74$ -1.87
Weighted Average Shares Outstanding
82.34M 75.97M 68.66M 67.62M 58.61M
Weighted Average Shares Outstanding (Diluted)
82.34M 75.97M 68.66M 67.62M 58.61M
Currency in USD

Editas Medicine Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis